New PPRS: two years of flat growth, no pricing role for NICE
This article was originally published in Scrip
Executive Summary
The UK Department of Health has published details of the new Pharmaceutical Price Regulation Scheme (PPRS) agreed with the industry body, the ABPI, under which the industry has agreed to keep NHS drug spending flat for the first two years of the scheme.